Although a small cohort of 11 samples was used, we found an increased expression and prominent nuclear localization of the proto-oncogene c-MYC in patients with MAFLD and MAFLD-related HCC, highlighting its potentially critical role for the disease progression. The gene discussed is MYC; the disease is hepatocellular carcinoma.